The anti-AChR antibody P90-131 targets acetylcholine receptor of which the high-level re-expression can occur after birth following denervation, including denervating neuromuscular diseases. The antibody can be used in the treatment of rhabdomyosarcoma.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-33 | Recombinant Anti-AChR Antibody | ELISA, WB, IF, FuncS | IgG |
FAMAB-0001WJ | Human Anti-AChR Recombinant Antibody (clone 587) | RIA, IP, IF | Human IgG |
FAMAB-0002WJ | Human Anti-AChR Recombinant Antibody (clone 637) | RIA, IF | Human IgG |
FAMAB-0029WJ | Human Anti-AChR Recombinant Antibody (clone MH6) | ELISA | Human IgG, λ |
VS-0723-CJ38 | Human Anti-AChR Recombinant Antibody (clone 131) | ELISA, WB, IF, Inhib, DB | Human IgG1 |
There are currently no Customer reviews or questions for TAB-0636CLV. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.